Autres langues BioSyent Inc.

Actions

RX

CA0906901081

Marché Fermé - Toronto S.E. Autres places de cotation 21:45:23 16/07/2024			Varia. 5j.	Varia. 1 janv.
10,15 ^CAD	+0,20 %		+1,00 %	+10,09 %

17/05	BioSyent Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
17/05	BioSyent Inc déclare un dividende pour le deuxième trimestre 2024, payable le 15 juin 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BioSyent In-Licenses Endocrinology Product for Canada	12/06
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.	17/05
BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	17/05
BioSyent Releases Financial Results for Q1 2024	17/05
BioSyent Declares Second Quarter 2024 Dividend	17/05
BioSyent Inc Declares Second Quarter 2024 Dividend, Payable June 15, 2024	17/05
BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024	09/05
BioSyent to Attend Planet MicroCap Showcase	23/04
BioSyent Inc.(TSXV:RX) dropped from S&P/TSX Venture Composite Index	22/04
BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement	15/04
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference	10/04
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year	03/04
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year	03/04
BioSyent To Present At LD Micro New York Investor Conference	01/04
BioSyent to Present at LD Micro New York Investor Conference	01/04
BioSyent Announces Grant of Restricted Share Units	27/03
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2022.	13/03
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.	13/03
BioSyent Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023	13/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BioSyent Inc.

Actions

RX

CA0906901081

Autres langues

Filtres